Actively Recruiting

Age: 2Years - 75Years
All Genders
Healthy Volunteers
ID07358910

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Led by Institut Pasteur du Cambodge · Updated on 2026-01-22

10000

Participants Needed

1

Research Sites

76 weeks

Total Duration

On this page

Sponsors

I

Institut Pasteur du Cambodge

Lead Sponsor

I

Institut Pasteur

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are investigating the spread and impact of multiple infectious diseases in Cambodia, a country facing challenges in disease surveillance and laboratory capacity. This nationwide study uses a One Health approach to better understand disease burden, transmission, and population immunity for a broad range of pathogens including zoonotic, vector-borne, vaccine-preventable, and neglected tropical diseases. The goal is to provide evidence that supports targeted and culturally appropriate public health interventions and to create a model that can be applied in similar low- and middle-income countries. The study will enroll about 10,000 participants aged 2 to 75 from urban and rural areas across Cambodia through a multi-stage population sampling method. Participants will complete standardized questionnaires covering demographics, health status, mobility, animal contact, and healthcare access. Blood samples will be collected for multiplex serology to detect antibodies against 57 priority pathogens. This observational study does not involve treatments but focuses on extensive data and sample collection to support research and policy development. Participants will be visited at home for blood sampling and questionnaire completion between December 2025 and April 2026. Researchers will measure the presence of antibodies to assess prior exposure to various pathogens. The study also includes building a biobank and curated datasets for long-term research use. Community engagement and collaboration with national stakeholders aim to facilitate the uptake of findings. The total participation period spans the inclusion period with no intervention, focusing on observation and data collection.

CONDITIONS

Brief Title

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Who Can Participate

Age: 2Years - 75Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Residency in the village for more than 6 months
  • Age between 2 and 75 years old at the time of inclusion
  • For adults: provision of written consent
  • For children aged 2-17 years: written parental consent form, verbal assent from children aged 13-17 years
Not Eligible

You will not qualify if you...

  • Unable to understand or consent
  • Under guardianship or deprived of liberty
  • Medical conditions that impede survey participation
  • Refusal to participate in the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Sample Collection

Duration - 5 months

Participants provide blood samples and complete questionnaires covering demography, health conditions, mobility, animal contact, and healthcare access.

Household visits during the inclusion period from December 2025 to April 2026

Long-term Monitoring

Duration - Until study completion in September 2027

Data and biospecimens are used to generate integrated evidence and support long-term research and public health decision-making.

No additional visits required for participants

Trial Site Locations

Total: 1 location

1

Institut Pasteur du Cambodge

Phnom Penh, Phnom Penh, Cambodia, 12201

Actively Recruiting

Loading map...

Research Team

C

Claude Flamand, Ph.D.

N

Najet Hadhri, MSc.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Randomized, Double-blind, Placebo/Positive Control Phase I...

Respiratory Syncytial Virus (RSV)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here